New Delhi, 3/11: India’s drug regulator, CDSCO, approved the extension of Bharat Biotech’s coronavirus vaccine Covaxin to 12 months from the date of manufacture.
Covaxin initially had a shelf life of six months when it first received emergency use approval in the country, which was later extended to nine months, a company spokeswoman told Reuters.
Additional stability data was submitted to CDSCO, the company said on Wednesday, after which the nod was given.
Comments are closed.